Tags

Type your tag names separated by a space and hit enter

[Therapeutic potential of micronized purified flavonoid fraction (MPFF) of diosmin and hesperidin in treatment chronic venous disorder].
Vnitr Lek. 2015 Sep; 61(9):807-14.VL

Abstract

Chronic venous disorder (CVD) is a common illness with high incidence existing especially in Europe and North America. The main goal of micronized purified flavonoid fraction (MPFF) of diosmin and hesperidin is to eliminate the symptoms of CVD (venous pain, fatigue, etc). But MPFF of diosmin and hesperidin has good effectiveness for treatment of venous oedema and venous ulcer too. There are many papers that prove its effectiveness in the experiment and in the microcirculation too. The other indications for MPFF of diosmin hesperidin is hemorrhoidal disease and the accessory treatment of lymphedema. It is proved that this substance could be used as an effective supplementary treatment of symptoms after venous intervention. Only MPFF diosmin and hesperidin received the best recommendation - 1B in the last guidelines for VAD therapy.

Authors

No affiliation info available

Pub Type(s)

Journal Article
Review

Language

cze

PubMed ID

26465280

Citation

Hnátek, Lukáš. "[Therapeutic Potential of Micronized Purified Flavonoid Fraction (MPFF) of Diosmin and Hesperidin in Treatment Chronic Venous Disorder]." Vnitrni Lekarstvi, vol. 61, no. 9, 2015, pp. 807-14.
Hnátek L. [Therapeutic potential of micronized purified flavonoid fraction (MPFF) of diosmin and hesperidin in treatment chronic venous disorder]. Vnitr Lek. 2015;61(9):807-14.
Hnátek, L. (2015). [Therapeutic potential of micronized purified flavonoid fraction (MPFF) of diosmin and hesperidin in treatment chronic venous disorder]. Vnitrni Lekarstvi, 61(9), 807-14.
Hnátek L. [Therapeutic Potential of Micronized Purified Flavonoid Fraction (MPFF) of Diosmin and Hesperidin in Treatment Chronic Venous Disorder]. Vnitr Lek. 2015;61(9):807-14. PubMed PMID: 26465280.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Therapeutic potential of micronized purified flavonoid fraction (MPFF) of diosmin and hesperidin in treatment chronic venous disorder]. A1 - Hnátek,Lukáš, PY - 2015/10/15/entrez PY - 2015/10/16/pubmed PY - 2016/2/26/medline SP - 807 EP - 14 JF - Vnitrni lekarstvi JO - Vnitr Lek VL - 61 IS - 9 N2 - Chronic venous disorder (CVD) is a common illness with high incidence existing especially in Europe and North America. The main goal of micronized purified flavonoid fraction (MPFF) of diosmin and hesperidin is to eliminate the symptoms of CVD (venous pain, fatigue, etc). But MPFF of diosmin and hesperidin has good effectiveness for treatment of venous oedema and venous ulcer too. There are many papers that prove its effectiveness in the experiment and in the microcirculation too. The other indications for MPFF of diosmin hesperidin is hemorrhoidal disease and the accessory treatment of lymphedema. It is proved that this substance could be used as an effective supplementary treatment of symptoms after venous intervention. Only MPFF diosmin and hesperidin received the best recommendation - 1B in the last guidelines for VAD therapy. SN - 0042-773X UR - https://www.unboundmedicine.com/medline/citation/26465280/[Therapeutic_potential_of_micronized_purified_flavonoid_fraction__MPFF__of_diosmin_and_hesperidin_in_treatment_chronic_venous_disorder]_ L2 - https://www.prolekare.cz/linkout/56071 DB - PRIME DP - Unbound Medicine ER -